USA: +1.610.230.0150
Europe: +44.330.122.0695
Central/Eastern Europe: +30.693.227.9127
Asia/Pacific: +03.2713.1956
Israel/Middle East: +972.77.693.5033
R&D Capabilities

Phase II / III Trials

The proven quality and experience of our clinical operations staff with Phase II/III testing in complex trials will serve you well.

We recently led a multi-site, multi-country phase III study in stage 4 lung cancer, a trial of enormous scale and complexity.

Our clinical expertise is complemented by outstanding budgeting, planning and consulting resources.